Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
18th Sep 20174:40 pmRNSSecond Price Monitoring Extn
18th Sep 20174:35 pmRNSPrice Monitoring Extension
15th Sep 20177:00 amRNSRe full year accounts
1st Sep 20178:47 amRNSHolding(s) in Company
31st Aug 20174:40 pmRNSSecond Price Monitoring Extn
31st Aug 20174:35 pmRNSPrice Monitoring Extension
23rd Aug 20175:46 pmRNSHolding(s) in Company
21st Aug 20177:30 amRNSRestoration - DX (Group) Plc
21st Aug 20177:00 amRNSResumption of trading in DX shares
14th Aug 20177:00 amRNSTermination of Discussions with John Menzies plc
14th Aug 20177:00 amRNSTermination of discussions with DX (Group) plc
14th Jul 20179:06 amRNSResponse to DX (Group) plc announcement
14th Jul 20177:00 amRNSTrading Update
7th Jul 20173:22 pmRNSResponse to DX (Group) plc announcement
7th Jul 20177:00 amRNSRe: City of London Police Investigation
30th Jun 20177:00 amRNSBoard Appointment
9th Jun 20178:00 amRNSResponse to DX (Group) plc announcement
9th Jun 20177:00 amRNSInvestigation by the City of London Police
5th Jun 20177:00 amRNSUpdate on Proposed Combination
5th Jun 20177:00 amRNSRe: John Menzies' Distribution Division - update
26th May 20171:27 pmRNSHolding(s) in Company
24th May 20175:55 pmRNSHolding(s) in Company
12th May 20177:00 amRNSAGM Trading Update
7th Apr 20171:45 pmRNSWithdrawal of Requisition of General Meeting
31st Mar 20177:30 amRNSSuspension - DX (Group) plc
31st Mar 20177:00 amRNSInterim Results
31st Mar 20177:00 amRNSRe: John Menzies' Distribution Division
31st Mar 20177:00 amRNSPotential combination of DX & Menzies Distribution
29th Mar 20177:00 amRNSMajor New Contract Win
21st Mar 20177:00 amRNSResponse to Requisition Notice
20th Mar 201711:17 amRNSRequisition of General Meeting
6th Mar 20177:00 amRNSChange of Registered Office
1st Mar 20177:00 amRNSRe: Proposed West Midlands Hub
9th Feb 20174:47 pmRNSHolding(s) in Company
8th Feb 201710:41 amRNSHolding(s) in Company
7th Feb 20177:00 amRNSTrading update
23rd Dec 201611:10 amRNSHolding(s) in Company
6th Dec 201610:59 amRNSResult of AGM
1st Dec 20167:00 amRNSReappointment to the Board
22nd Nov 20167:00 amRNSHMPO Contract and Trading Update
21st Nov 20167:00 amRNSRe: Annual General Meeting
15th Nov 20167:00 amRNSPosting of Accounts & Notice of AGM
4th Nov 20164:40 pmRNSSecond Price Monitoring Extn
4th Nov 20164:35 pmRNSPrice Monitoring Extension
21st Oct 20167:11 amRNSRe CMA Review - Investigation Now Closed
7th Oct 20163:10 pmRNSHolding(s) in Company
26th Sep 20166:22 pmRNSHolding(s) in Company
26th Sep 20164:40 pmRNSSecond Price Monitoring Extn
26th Sep 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.